期刊文献+

卵巢癌细胞MHC-Ⅰ类抗原表达与肿瘤微环境免疫细胞分布关系 被引量:4

Correlation Study between Expression of MHC ⅠMolecule in Ovarian Carcinoma and T-cell Infiltration in vivo on Ovarian Carcinoma Milieu
下载PDF
导出
摘要 目的 探讨卵巢癌细胞MHC Ⅰ类分子表达与肿瘤微环境免疫活性细胞分布的关系 ,了解机体肿瘤微环境免疫功能状态。方法 用流式细胞仪检测卵巢癌细胞MHC Ⅰ类分子表达 ,同时用免疫组化方法检测肿瘤微环境中LCA+ 、CD3 + 细胞分布情况。结果 卵巢癌细胞MHC Ⅰ类分子表达存在不同程度的下降或缺如 ,且与肿瘤微环境中LCA+ 、CD3 + 细胞分布呈正相关 ,前者r=0 .846 ,P =0 .0 0 0 1,后者r =0 .738,P =0 .0 0 0 1。结论 上皮性卵巢癌细胞MHC Ⅰ类抗原分子的表达影响肿瘤微环境中浸润免疫细胞数 ,进而影响肿瘤微环境免疫监视能力。检测MHC Ⅰ类分子表达可为肿瘤浸润淋巴细胞临床过继治疗选择合适病例提供实验依据。 Purpose To determine the correlation between expression of MHC class Ⅰ on ovarian tumor cells and T cell infiltration in vivo on ovarian tumor micro environment. Methods Thirty three samples of primary epithelial ovarian carcers were analysed with flow cytometry for MHC class Ⅰ expression.Immunohistochemical analysis was performed using monoclonal antibodies that recognize leukocyte differentiation antigens(LCA +,CD 3 +) on cryostat sections of primary epithelial ovarian carcinoma.The results were compared with the expression of MHC class Ⅰexpression. Results Close correlation were revealed bewteen the expression of MHC class Ⅰ molecules and the numbers of infiltrating LCA + positive cells ( r=0.846,P=0.000 1) and CD 3 + cells ( r=0.738,P=0.000 1 ). Conclusions Expression of MHC class Ⅰ molecules may influence the status of human immunosurveillance in tumor micro environment on ovarian carcinoma and the assay may be helpful in selection patients for adoptive immnotherapy.
出处 《上海医科大学学报》 CSCD 2000年第3期201-203,207,F003,共5页 Journal of Fudan University(Medical Science)
关键词 MHC-Ⅰ类分子 卵巢癌 肿瘤浸润 微环境免疫细胞 MHC class Ⅰ molecules ovarian carcinoma tumor infiltrating lymphocytes
  • 相关文献

参考文献3

  • 1Lin M,Int J Cancer,1998年,78卷,112页 被引量:1
  • 2Han X,Gymecol Oncol,1997年,65卷,391页 被引量:1
  • 3Cheng A E,Crit Rev Oncol Hematol,1996年,22卷,213页 被引量:1

同被引文献33

  • 1及和照.肿瘤细胞表面的MHC抗原[J].国外医学(免疫学分册),1996,19(5):264-266. 被引量:14
  • 2章卫平,曹雪涛,滨田洋文.COS/TPC同源重组法高效制备人B7(CD80)重组腺病毒[J].中国肿瘤生物治疗杂志,1997,4(1):10-13. 被引量:5
  • 3Greenfield EA,Nguyen KA,Kuchroo VK.CD28/B7 costimulation:a review[J].Crit Rev Immunol,1998,18(5):389-418. 被引量:1
  • 4Judge TA,Tang A,Turka LA.Immunosuppression through blockade of CD80:B7 mediated costimulatory signals[J].Immunol Res,1996,15(6):38-49. 被引量:1
  • 5Tomita Y.Major histocompatibility comples class Ⅱ antigens on renal cell cancer-immunohistochemical study and efection their expression by interferon[J].Nippon-Hinypkija Gakkaj Zasshi,1990,81(7):1 079-1 086. 被引量:1
  • 6Steimle V,Siegrist CA,Mottet A,et al.Regulation of MHC class Ⅱ expression by interferon-gamma mediated by the transactivator gene CIITA[J].Science,1994,265(5 168):106-108. 被引量:1
  • 7Rock K L.A new foreign policy:MHC class I molecules monitor the outside world. Immunology Today . 1996 被引量:1
  • 8Bookman M A.Biological therapy of ovarian cancer:current directions. Seminars in Oncology . 1998 被引量:1
  • 9Sjarlot Kooi Hua-Zhong Zhang Rebecca Patenia Creighton L. Edwards Chris D. Platsoucas and Ralph S. Freedman.HLA Class I Expression on Human Ovarian Carcinoma Cells Correlates with T-Cell Infiltrationin Vivoand T-Cell Expansionin Vitroin Low Concentrations of Recombinant Interleukin-2. Cellular Immunology . 1996 被引量:1
  • 10邹雄,徐从高.MHC和肿瘤转移[J].国外医学(肿瘤学分册),1997,24(5):289-291. 被引量:4

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部